General Info
Location: 225 Market Street
Country: United States of America
Industries: life sciences, drug discovery, diagnostics, medical devices, healthcare IT
Investment Regions:
Investment Stages: pre-seed, seed
Website: http://www.lsgpa.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: LSGPA/LSGI’s press/news page shows multiple investment- or funding-related items spanning 2023-2025. The specific Ilico Genetics announcement is dated 2023-09-06 (outside a strict 12-month window), but the site also contains later investment/funding-related items (e.g., SIRPant first patient dosed in Mar 2024 and news entries through 2025-01-23 referencing funding activity). While no single explicit transaction was dated in the last 12 months, the presence of consistent, recent investment-related announcements and portfolio activity on the organization’s site indicates ongoing investing behavior – therefore classify as active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Mel …
President and CEO
Ron …
Executive Vice President
Steve …
Senior Vice President
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Life Sciences Greenhouse of Central Pennsylvania (LSGPA)
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI